Ovarian Cancer Prognosis Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Ovarian Cancer Prognosis Biography

source(google.com.pk)
    Partial hysterectomy or total hysterectomy. A partial hysterectomy removes your uterus, and a total hysterectomy removes your uterus and your cervix. Both procedures leave your ovaries and fallopian tubes intact, so you can still develop ovarian cancer.
    Total hysterectomy with salpingo-oophorectomy. This procedure removes your cervix and uterus as well as both ovaries and fallopian tubes. This makes ovarian cancer less likely to occur, but it does not remove all risk. You still have a small risk of what's called primary peritoneal cancer, which acts just like ovarian cancer and is treated similarly. Peritoneal cancer may result from ovarian cells that migrated to the peritoneal area during each menstrual cycle before your ovaries were removed. These cells can become cancerous later on. Alternatively, since the peritoneum and ovaries arise from the same tissues during embryonic development, it's possible that cancer could arise from the cells of the peritoneum.

A Pap test is a screening test for cervical cancer, but it can't detect ovarian cancer. Currently, there are no effective screening tests for ovarian cancer. If you've had your cervix removed as part of a total hysterectomy, you usually don't need an annual Pap test. But if your hysterectomy was done because of cancer of the cervix or abnormal cells were previously found on the surface of your cervix (dysplasia), your doctor may recommend continued Pap tests.

You may still need regular pelvic exams after hysterectomy. Ask your doctor how often you should have a pelvic exam.

Ovarian Cancer Prognosis Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Ovarian Cancer Prognosis Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Ovarian Cancer Prognosis Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Ovarian Cancer Prognosis Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Ovarian Cancer Prognosis Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Ovarian Cancer Prognosis Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Ovarian Cancer Prognosis Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Ovarian Cancer Prognosis Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Ovarian Cancer Prognosis Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Ovarian Cancer Prognosis Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Ovarian Cancer Prognosis Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Ovarian Cancer Prognosis Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer In ChildrenSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer In Children Biography

Source(google.com.pk)

Congressman Michael T. McCaul, co-chair and founder of the Childhood Cancer Caucus, is currently serving his fourth term representing Texas' 10th District in the United States Congress. The 10th Congressional District of Texas stretches from Austin to the Houston suburbs, and includes Austin, Bastrop, Burleson, Harris, Lee, Travis, Washington and Waller Counties.

Congressman McCaul formed the bipartisan Childhood Cancer Caucus with former Congressman Joe Sestak, whose daughter, Alex, is a childhood cancer survivor.  For Congressman McCaul, his passion for fighting pediatric cancer started at an early age when he lost a childhood friend to leukemia.  Shortly after being elected to Congress, Congressman McCaul was introduced to constituents in his district who lost their own children to cancer.  As a parent of five children, Congressman McCaul felt compelled to use his position in the Congress to raise awareness about childhood cancer, advocate in supporting measures which will improve the lives of patients, and work toward eliminating childhood cancer as a threat to all children.

COMMITTEES AND CAUCUSES
Congressman McCaul is a member of the House Committees on Homeland Security, Foreign Affairs, Science, Space and Technology, and Ethics.  He is also founder and Co-Chair of the Congressional High Technology Caucus, Green Schools Caucus, Congressional Cyber Security Caucus, and the Sudan Caucus.

PERSONAL
Prior to coming to Congress, Michael McCaul served as Chief of Counter Terrorism and National Security in the U.S. Attorney’s office in Texas, and led the Joint Terrorism Task Force charged with detecting, deterring and preventing terrorist activity. Congressman McCaul also served as Texas Deputy Attorney General under current U.S. Senator John Cornyn, and served as a federal prosecutor in the Department of Justice’s Public Integrity Section in Washington, D.C.  A fourth generation Texan, Congressman McCaul earned a B.A. in Business and History from Trinity University and holds a J.D. from St. Mary's University School of Law. In 2009 Congressman McCaul was honored with St. Mary's Distinguished Graduate award.  He is also a graduate of the Senior Executive Fellows Program of the School of Government, Harvard University.  Congressman McCaul is married to his wife, Linda, who is the Chair of the Pediatric Cancer Committee at M.D. Anderson Cancer Treatment and Research Center in Houston.  They are proud parents of five children: Caroline, Jewell, and the triplets Lauren, Michael and Avery

Cancer In ChildrenSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer In ChildrenSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer In ChildrenSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer In ChildrenSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer In ChildrenSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer In ChildrenSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer In ChildrenSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer In ChildrenSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer In ChildrenSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer In ChildrenSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer In ChildrenSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Cancer In ChildrenSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Information About CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Information About Cancer Biography

Source(google.com.pk)

Otis W. Brawley, M.D., F.A.C.P., chief medical officer for the American Cancer Society, is responsible for promoting the goals of cancer prevention, early detection, and quality treatment through cancer research and education. He champions efforts to decrease smoking, improve diet, detect cancer at the earliest stage, and provide the critical support cancer patients need. He also guides efforts to enhance and focus the research program, upgrade the Society’s advocacy capacity, and concentrate community cancer control efforts in areas where they will be most effective. Further, as an acknowledged global leader in the field of health disparities research, Dr. Brawley is a key leader in the Society’s work to eliminate disparities in access to quality cancer care.

Dr. Brawley currently serves as professor of hematology, oncology, medicine and epidemiology at Emory University. From April of 2001 to November of 2007, he was medical director of the Georgia Cancer Center for Excellence at Grady Memorial Hospital in Atlanta, and deputy director for cancer control at Winship Cancer Institute at Emory University. He has also previously served as a member of the Society’s Prostate Cancer Committee, co-chaired the U.S. Surgeon General’s Task Force on Cancer Health Disparities, and filled a variety of capacities at the National Cancer Institute (NCI), most recently serving as assistant director.

Dr. Brawley is a member of the Centers for Disease Control and Prevention Advisory Committee on Breast Cancer in Young Women. He was formerly a member of the Centers for Disease Control and Prevention Breast and Cervical Cancer Early Detection and Control Advisory Committee. He served as a member of the Food and Drug Administration Oncologic Drug Advisory Committee and chaired the National Institute of Health Consensus Panel on the Treatment of Sickle Cell Disease. He is listed by Castle Connelly as one of America’s top doctors for cancer. Among numerous other awards, he was a Georgia Cancer Coalition Scholar and received the Key to St. Bernard Parish for his work in the U.S. Public Health Service in the aftermath of Hurricane Katrina.

Dr. Brawley is a graduate of University of Chicago, Pritzker School of Medicine. He completed his internship at University Hospitals of Cleveland, Case-Western Reserve University, his residency at University Hospital of Cleveland, and his fellowship at the National Cancer Institute.

 Information About CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Information About CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Information About CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Information About CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Information About CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Information About CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Information About CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Information About CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Information About CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Information About CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

 Information About CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Symptoms Ovarian CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Symptoms Ovarian Cancer Biography

Source(google.com.pk)

Ovarian cancer is created by the abnormal and uncontrolled growth of cells and it can spread more widely in the stomach through the bloodstream or the lymph system where it can grow and form secondary tumours.

There are two main types of ovarian cancer. The most common (9 out of 10) is epithelial which affects the lining of the ovaries. There are several different types of epithelial ovarian cancer including the two most common – serous and endometrioid. Non-epithelial ovarian cancer is much less common. These include germ cell cancers that form from the cells in the ovary that make the eggs. These usually affect younger women.
Symptoms of ovarian cancer
One of the major problems in diagnosing ovarian cancer is that there are very few, if any, symptoms in the early stages which is why it is known as the ’silent killer’. Late detection is one reason why ovarian cancer is notoriously difficult to treat and the American Cancer Society estimates that 22,000 women in the United States are diagnosed with HGSOC each year, and 14,000 die of it. Worldwide, the incidence approaches 200,000 women with 115,000 deaths each year.

If there are symptoms, they can include stomach pain or a bloated feeling that can be confused with irritable bowel syndrome (IBS). Ovarian cysts and non-cancerous growths also cause the same symptoms as ovarian cancer.

Symptoms Ovarian CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Symptoms Ovarian CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Symptoms Ovarian CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Symptoms Ovarian CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Symptoms Ovarian CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Symptoms Ovarian CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Symptoms Ovarian CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Symptoms Ovarian CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Symptoms Ovarian CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Symptoms Ovarian CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Symptoms Ovarian CancerSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Breast Cancer Signs Sign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Breast Cancer Signs Biography

Source(google.com.pk)

FORT WAYNE and WEST LAFAYETTE, Ind. - Matrix-Bio Inc., a diagnostics company that uses metabolite profiling to detect cancer and other diseases, has signed an exclusive global licensing and marketing agreement for metabolomic biomarkers with Quest Diagnostics (NYSE: DGX).

Quest is the world's leading provider of diagnostic information services. Under the agreement, Quest will have the rights to use the biomarkers for the future potential development of a clinical laboratory-developed test to aid in the detection of breast cancer recurrence. The company plans to independently develop and validate the laboratory-developed test from its Quest Diagnostics Nichols Institute in San Juan Capistrano, Calif., where it houses a research, development and laboratory center.

The company will co-fund clinical studies with Matrix-Bio to demonstrate the clinical value of the test using the metabolomic biomarkers and, assuming successful validation, offer its own version of the test through the San Juan Capistrano laboratory and market the testing service in the United States and other countries. Quest Diagnostics also has the option to pursue an appropriate regulatory pathway for an in vitro diagnostic version of the test. Additional terms were not disclosed.

Matrix-Bio has developed a technique that uses mass spectrometry and nuclear magnetic resonance spectroscopy to identify metabolic changes occurring in cancerous cells. In 2010 Cancer Research, a peer-reviewed publication of the American Association of Cancer Research, published Matrix-Bio's findings, Early Detection of Recurrent Breast Cancer Using Metabolite Profiling. Using metabolite-profiling methods, Matrix-Bio's laboratory-developed test correctly predicted a recurrence of breast cancer an average of 13 months before clinical diagnosis and two times the sensitivity of the current standard tests involving immunoassays.

"Our relationship with Matrix-Bio builds on Quest's leadership in oncology and mass spectrometry and moves us forward in the emerging field of metabolomic clinical diagnostics," said Jay Wohlgemuth, M.D., Quest's senior vice president, science and innovation. "It also delivers on a central tenet of our strategy to deliver a robust menu of services, in this case for breast cancer, which spans the continuum of care, from predisposition genetic testing to post-surgical monitoring."

Commenting on the agreement, Matrix-Bio founder and chief scientific officer Dan Raftery, Ph.D., said collaboration with a company of the stature of Quest Diagnostics could advance the potential commercialization of a novel breast cancer recurrence test.

"Since 2006 when we first started working on metabolite profiling as a cancer detection tool, we have had the ideal partner in mind to help bring this potentially life-saving technology to those at risk of cancer," Raftery said. "Licensing the biomarkers to Quest Diagnostics is a big step toward our goal to make improved and more efficient testing methods for diagnosing many forms of cancer available to physicians and patients. Quest has the people, processes and presence to bring a clinically valuable breast cancer recurrence test to market and, with it, hope to breast cancer survivors who want more accurate cancer recurrence monitoring."

Matrix-Bio is developing additional biomarkers that may provide the basis for tests for other cancers utilizing its patent-pending VeraMarker™ metabolite profiling technology platform. Raftery founded Matrix-Bio while a professor of analytical and physical chemistry at Purdue University in West Lafayette, Ind., where he received entrepreneurial support from the Purdue Research Foundation Office of Technology Commercialization.

Raftery is now a medical education and research endowed professor in the Department of Anesthesia and Pain Medicine and director of the Northwest Metabolomics Research Center at the University of Washington in Seattle. He is also a member of the Fred Hutchinson Cancer Research Center (http://www.fhcrc.org) in Seattle. Raftery's work is supported by the National Institutes of Health and U.S. Department of Defense.

Breast Cancer SignsSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Breast Cancer SignsSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Breast Cancer SignsSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Breast Cancer SignsSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Breast Cancer SignsSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Breast Cancer SignsSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Breast Cancer SignsSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Breast Cancer SignsSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Breast Cancer SignsSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos

Breast Cancer SignsSign Ribbon cells Horoscope Symbol Tattoos Research Zodiac Sign Ribbon Tattoos